We are at a watershed brought on by the recent introduction of highly effective obesity medications. As the development of these medications continues to evolve, obesity research will hold a prominent position over the next several decades. These new pharmacotherapeutics can potentially help transform the lives and health of people with obesity, and hold promise for the health of our nation and world.
Yale Obesity Research Center (Y-Weight)
The United States is at the forefront of the global obesity epidemic with estimates indicating that half of Americans will have obesity by 2030 (body mass index =30kg/m2). Obesity is a complex, chronic disease in and of itself and, additionally, it has driven substantial increases in obesity-related conditions, such as Type 2 diabetes, cardiovascular disease, and even some types of cancer.
How to Help
Y-Weight Research
The focus of Y-Weight (the Yale Obesity Research Center) is to investigate novel obesity medications and to use these medications to help us better understand the biology of obesity. The three areas of clinical research at Y-Weight include: 1) human physiology studies (to better understand the biology of obesity), 2) clinical trials (to assess the efficacy and safety of novel obesity medications), and 3) outcomes research (to investigate how these medications are used work in the real-world and impact population health).
- July 17, 2025
Once-Monthly Obesity Medication Shows Promise for Those With and Without Type 2 Diabetes
- June 02, 2025
New Professors in the Department of Internal Medicine
- May 05, 2025
Why Aren’t People Who Need Weight Loss Drugs Getting Them?
- February 12, 2025Source: WTNH
Weight Loss Revolution Part 1: The pros and cons of weight loss drugs